Advertisement

Analytical and Bioanalytical Chemistry

, Volume 408, Issue 4, pp 1125–1135 | Cite as

Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS

  • Tianhu Liu
  • Jiaxun Li
  • Fengcheng Xu
  • Mengni Wang
  • Shijia Ding
  • Hongbing XuEmail author
  • Fang DongEmail author
Research Paper

Abstract

Gestational diabetes mellitus (GDM) refers to the first sign or onset of diabetes mellitus during pregnancy rather than progestation. In recent decades, more and more research has focused on the etiology and pathogenesis of GDM in order to further understand GDM progress and recovery. Using an advanced metabolomics platform based on ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF-MS), we explored the changes in serum metabolites between women with GDM and healthy controls during and after pregnancy. Some significant differences were discovered using multivariate analysis including partial least-squares discriminant analysis (PLS-DA) and orthogonal PLS-DA (OPLS-DA). The dysregulated metabolites were further compared and verified in several databases to understand how these compounds might function as potential biomarkers. Analyses of the metabolic pathways associated with these potential biomarkers were subsequently explored. A total of 35 metabolites were identified, contributing to GDM progress to some extent. The identified biomarkers were involved in some important metabolic pathways including glycine, serine, and threonine metabolism; steroid hormone biosynthesis; tyrosine metabolism; glycerophospholipid metabolism; and fatty acid metabolism. The above mentioned metabolic pathways mainly participate in three major metabolic cycles in humans, including lipid metabolism, carbohydrate metabolism, and amino acid metabolism. In this pilot study, the valuable comprehensive analysis gave us further insight into the etiology and pathophysiology of GDM, which might benefit the feasibility of a rapid, accurate diagnosis and reasonable treatment as soon as possible but also prevent GDM and its related short- and long-term complications.

Keywords

Gestational diabetes mellitus Metabolomics Biomarkers Pathogenesis UPLC/Q-TOF-MS 

Notes

Acknowledgments

This study was supported by the fundamental and advanced research projects (20140121) and science and technology research projects (Chongqing Education Commission, KJ1400221). The authors also sincerely thank the research subjects who participated in the studies described in this report.

Compliance with ethical standards

The study protocol was approved by the Ethics Committee of Chongqing Medical University, China. All participants signed an informed consent prior to inclusion in this study.

Conflict of interest

The authors declare that they have no competing interests.

Supplementary material

216_2015_9211_MOESM1_ESM.pdf (49 kb)
ESM 1 (PDF 49 kb)

References

  1. 1.
    Gabbe SG, Graves CR (2003) Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 102:857–868CrossRefGoogle Scholar
  2. 2.
    Angueira AR, Ludvik AE, Reddy TE, Wicksteed B, Lowe WL Jr, Layden BT (2015) New insight into gestational glucose metabolism: lessons learned from 21st century approaches. Diabetes 64:327–334CrossRefGoogle Scholar
  3. 3.
    Zhang F, Dong L, Zhang CP et al (2011) Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet Med 28:652–657CrossRefGoogle Scholar
  4. 4.
    Metzger BE, Gabbe SG, Persson B et al (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefGoogle Scholar
  5. 5.
    Metzger BE, Coustan DR (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus: the organizing committee. Diabetes Care 21:161–167Google Scholar
  6. 6.
    Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Investig 115:485–491CrossRefGoogle Scholar
  7. 7.
    Hedderson MM, Ferrara A, Sacks DA (2003) Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol 102:850–856CrossRefGoogle Scholar
  8. 8.
    Chen YZ, Quick WW, Yang W et al (2009) Cost of gestational diabetes mellitus in the United States in 2007. Popul Health Manag 12:165–174CrossRefGoogle Scholar
  9. 9.
    Wen SW, Liu S, Kramer MS et al (2000) Impact of prenatal glucose screening on the diagnosis of gestational diabetes and on pregnancy outcomes. Am J Epidemiol 152:1009–1014CrossRefGoogle Scholar
  10. 10.
    Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH (2002) Macrosomia despite good glycaemic control in type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 45:1484–1489CrossRefGoogle Scholar
  11. 11.
    Xiong X, Saunders LD, Wang FL, Demianczuk NN (2001) Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynecol Obstet 75:221–228CrossRefGoogle Scholar
  12. 12.
    Ferrara A, Weiss NS, Hedderson MM et al (2007) Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 50:298–306CrossRefGoogle Scholar
  13. 13.
    Ruchat SM, Hivert MF, Bouchard L (2013) Epigenetic programming of obesity and diabetes by in utero exposure to gestational diabetes mellitus. Nutr Rev 71:S88–S94CrossRefGoogle Scholar
  14. 14.
    Shah BR, Retnakaran R, Booth GL (2008) Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 31:1668–1669CrossRefGoogle Scholar
  15. 15.
    Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Yogev Y (2013) Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98:4227–4249CrossRefGoogle Scholar
  16. 16.
    Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189CrossRefGoogle Scholar
  17. 17.
    Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153–161CrossRefGoogle Scholar
  18. 18.
    Gika HG, Theodoridis GA, Plumb RS, Wilson ID (2014) Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J Pharm Biomed Anal 87:12–25CrossRefGoogle Scholar
  19. 19.
    Haoula Z, Ravipati S, Stekel DJ et al (2015) Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. Metabolomics 11:657–666CrossRefGoogle Scholar
  20. 20.
    Nicholson JK, Lindon JC (2008) Systems biology: metabonomics. Nature 455:1054–1056CrossRefGoogle Scholar
  21. 21.
    Blow N (2008) Metabolomics: biochemistry’s new look. Nature 455:697–700CrossRefGoogle Scholar
  22. 22.
    Dong F, Deng D, Chen H et al (2015) Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach. Anal Bioanal Chem 407:4683–4695CrossRefGoogle Scholar
  23. 23.
    Farag MA, Gad HA, Heiss AG, Wessjohann LA (2014) Metabolomics driven analysis of six Nigella species seeds via UPLC-q TOF-MS and GC–MS coupled to chemometrics. Food Chem 151:333–342CrossRefGoogle Scholar
  24. 24.
    Diaz SO, Pinto J, Graca G et al (2011) Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. J Proteome Res 10:3732–3742CrossRefGoogle Scholar
  25. 25.
    Sachse D, Sletner L, Mørkrid K et al (2012) Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes. PLoS One 7, e52399CrossRefGoogle Scholar
  26. 26.
    Graça G, Duarte IF, Barros AS et al (2010) Impact of prenatal disorders on the metabolic profile of second trimester amniotic fluid: a nuclear magnetic resonance metabonomic study. J Proteome Res 9:6016–6024CrossRefGoogle Scholar
  27. 27.
    Graça G, Goodfellow BJ, Barros AS et al (2012) UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers. Mol BioSyst 8:1243–1254CrossRefGoogle Scholar
  28. 28.
    Song HH, Kim DY, Woo S, Lee HK, Oh SR (2013) An approach for simultaneous determination for geographical origins of Korean Panax ginseng by UPLC-QTOF/MS coupled with OPLS-DA models. J Ginseng Res 37:341–348CrossRefGoogle Scholar
  29. 29.
    Westerhuis JA, van Velzen EJJ, Hoefsloot HC, Smilde AK, Smilde AK (2010) Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. Metabolomics 6:119–128CrossRefGoogle Scholar
  30. 30.
    Young SP, Kapoor SR, Viant MR et al (2013) The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum 65:2015–2023CrossRefGoogle Scholar
  31. 31.
    Hu X, Li H, Tang P, Sun J, Yuan Q, Li C (2013) GC–MS-based metabolomics study of the responses to arachidonic acid in Blakeslea trispora. Fungal Genet Biol 57:33–41CrossRefGoogle Scholar
  32. 32.
    Knowler WC, Fowler SE, Hamman RF et al (2009) 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet 374:1677–1686CrossRefGoogle Scholar
  33. 33.
    Dudzik D, Zorawski M, Skotnicki M et al (2014) Metabolomics fingerprint of gestational diabetes mellitus. J Proteome 103:57–71CrossRefGoogle Scholar
  34. 34.
    Vejrazkova D, Vcelak J, Vankova M et al (2014) Steroids and insulin resistance in pregnancy. J Steroid Biochem Mol Biol 139:122–129CrossRefGoogle Scholar
  35. 35.
    Lacroix M, Kina E, Hivert MF (2013) Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life. Curr Diab Rep 13:238–244CrossRefGoogle Scholar
  36. 36.
    Iva SK (2013) Metabolic adaptations in pregnancy in lean and obese women—a literature review. Res Obstet Gynecol 2:37–47Google Scholar
  37. 37.
    Catalano PM (2010) Obesity, insulin resistance, and pregnancy outcome. Reproduction 140:365–371CrossRefGoogle Scholar
  38. 38.
    Carr DB, Utzschneider KM, Hull RL et al (2006) Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 29:2078–2083CrossRefGoogle Scholar
  39. 39.
    Agarwal MM, Punnose J, Dhatt GS (2004) Gestational diabetes: implications of variation in post-partum follow-up criteria. Eur J Obstet Gynecol Reprod Biol 113:149–153CrossRefGoogle Scholar
  40. 40.
    Ogonowski J, Miazgowski T (2009) The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res Clin Pract 84:239–244CrossRefGoogle Scholar
  41. 41.
    Jelsma JG, van Poppel MNM, Galjaard S et al (2013) DALI: vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial-study protocol. BMC Pregnancy Childbirth 13:142CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Pi County People’s HospitalChengduChina
  2. 2.Department of Obstetrics and GynecologyThe First Affiliated Hospital of Chongqing Medical UniversityChongqingChina
  3. 3.Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory MedicineChongqing Medical UniversityChongqingChina
  4. 4.Department of Endocrinology &The First BranchThe First Affiliated Hospital of Chongqing Medical UniversityChongqingChina

Personalised recommendations